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Background: Rapid expansion of antiretroviral therapy in Malawi has occurred in the relative absence
of suitable pediatric CD4 counting facilities. We have recently validated in adults a simpliﬁed affordable
ﬂow cytometric CD4 counting method, the Blantyre count. There is a need for this technology to transfer
to government laboratories run by local staff, and to be validated in children, where %CD4/lymphocyte
values are required.
Methods: We assessed agreement of %CD4/lymphocyte values determined by the Blantyre count and
Panleucogate methods on an EPICS XL-MCL ﬂow cytometer on 113 venous blood samples from HIV-sero-
positive children in Blantyre, Malawi. All assays were performed by two Malawian laboratory technicians.
Results: Overall bias between the two methods was 20.13% (95% CI 20.37 to 0.11) and limits of
agreement were 22.69 to 2.43% (95% CI 23.11 to 22.27 and 2.01 to 2.85). Limits of agreement were
within 23.00 and 3.00 for each laboratory technician. Coefﬁcient of variation for the Blantyre count assay
was 2.0% and samples showed good stability over 5 days.
Conclusions: The Blantyre count method can accurately determine %CD4/lymphocyte values in blood of
HIV-seropositive children on an EPIC XL-MCL ﬂow cytometer at a reagent cost of US $0.21 per test or less.
The assay can be competently carried out by local laboratory technicians. q 2008 Clinical Cytometry Society
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q 2008 Clinical Cytometry SocietyThe facility of ﬂow cytometry to rapidly analyze the
surface characteristics of cells makes it ideally suited for
determining relative levels of cell populations within a
blood sample. For this reason, ﬂow cytometry is the
gold-standard platform for measuring CD4 cells as a per-
centage of total lymphocyte count (%CD4/lymphocyte)
as required for the immunological staging and monitor-
ing of HIV-infected children below 5 years of age (1,2).
Antiretroviral therapy for the treatment of HIV/AIDS
became freely available at the point of delivery in gov-
ernment clinics in Malawi in 2004. Since then, there has
been a rapid scaling-up in the provision of antiretroviral
therapy for both children and adults. By the end of June
2007 in public sector clinics, 110,075 individuals had
been commenced on treatment, of whom 8% are chil-
dren aged 14 years and below (3).
The decision to start an HIV-infected individual on
antiretroviral therapy in Malawi has been largely based
on clinical staging criteria so that those with WHO stage
III and IV HIV/AIDS are commenced on therapy,
whereas those with stage I and II disease are not. We
have previously shown the limitations of this approach
when used among adult Malawians presenting to the
antiretroviral therapy clinic at Queen Elizabeth Central
Hospital, Blantyre. Thirty-eight percent of new adult
patients attending the antiretroviral therapy clinic with
clinical Stage I and II disease were severely immunosup-
pressed with CD4 counts <200 cells/ll, while 20% with
Stage III and IV disease had CD4 counts >350 cells/ll
(4). In Malawian children, there are similar limitations in
using WHO clinical staging criteria, particularly in a coun-
try where 48% of below 5 years old are stunted, 22% are
underweight, and 5% are wasted. These clinical features
form part of the WHO staging criteria, but are predomi-
nantly due to factors other than HIV in Malawi (5).
Where CD4 counts have been available in Malawi,
both at Queen Elizabeth Central Hospital and elsewhere,
these tests have mostly been performed using FACS-
Count (Becton Dickinson) dedicated CD4 counting instru-
ments (6). The FACSCount provides absolute CD3, CD4,
and CD8 counts, but is currently unable to generate CD4
counts as a percentage of the total lymphocyte count
(%CD4/lymphocyte) without obtaining a separate total
lymphocyte count from a hematological analyzer. The
%CD4/lymphocyte can then be calculated by dividing the
CD4 count from the FACSCount instrument with the total
lymphocyte count from the hematological analyzer.
Such a ‘‘reversed dual-platform’’ approach is unneces-
sarily cumbersome and expensive as it requires the use
of two instruments, when even the most basic ﬂow
cytometers can generate %CD4/lymphocyte values on a
single platform. Importantly, we have shown that this
reversed dual-platform approach is inherently inaccurate
when compared with established single-platform ﬂow
cytometric CD4 counting. Comparing %CD4/lymphocyte
values obtained using FACSCount and a hematological
analyzer with those obtained using Multitest with Tru-
Count tubes (TruCount assay, Becton Dickinson) on a
FACSCalibur ﬂow cytometer (Becton Dickinson), we
found unacceptably wide limits of agreement (25.83 to
7.66%, 95% CI 26.87 to 24.79 and 6.62 to 8.70) (4). (A
modiﬁcation of the FACSCount system that will deter-
mine %CD4/lymphocyte values has recently been tested
(7) and should become available in due course.)
The CyFlow Counter (Partec) has been proposed as
an alternative dedicated CD4 counting instrument for
Malawi and has been used by Mede ´cins Sans Frontie `res
in this country. Information is not available concerning
its use in %CD4/lymphocyte determination in children in
Malawi. However, a study comparing accuracy of the
CyFlow Counter with FACSCount for producing absolute
CD4 counts at Chiradzulu District Hospital in Malawi
found poor limits of agreement between the two assays
that were greater than 2150 to 150 cells/ll (8).
In the past few years, a small number of larger ﬂow
cytometers have appeared in Malawi, principally in
research settings, but more recently in regional govern-
ment hospitals, nongovernmental organization clinics,
and in a laboratory of the national medical school. These
have provided the opportunity to use a single-platform
approach for determining both absolute CD4 counts and
%CD4/lymphocyte.
TruCount and Panleucogate (Beckman Coulter) (9)
commercial kit-based ﬂow cytometric CD4 counting
assays for use on these larger cytometer platforms are
available in Malawi for US $5–6 reagent cost per test.
These prices represent a signiﬁcant saving on the price
of such kits in developed countries, but are still too ex-
pensive for the widespread introduction of ﬂow cyto-
metric CD4 counting in Malawi, especially when consid-
ering the cost of annual maintenance contracts of
approximately $12,000 for each ﬂow cytometer.
In South Africa, the successful Panleucogate/EPICS XL-
MCL cytometer-based national CD4 counting program
(10) provides absolute and percentage CD4 counts at an
equivalent reagent price of $3 per test with the manufac-
turer covering the cost of instrument installation, mainte-
nance, training, and quality assurance. Such a cost-effec-
tive agreement is possible because of the large number of
predicted CD4 assays per year country-wide. Only ﬁve
EPICS cytometers are currently sited in Malawi, and there
is no uniﬁed national arrangement on CD4 counting.
To offset the high capital outlay of ﬂow cytometers
and their annual maintenance programs in Malawi, we
have recently optimized and validated an accurate and
affordable method of ﬂow cytometric CD4 counting, the
Blantyre count, on a FACSCalibur ﬂow cytometer at the
Malawi-Liverpool-Wellcome Trust Clinical Research Pro-
gramme. Absolute CD4 and %CD4/lymphocyte enumera-
tion are performed at a reagent cost of $0.44, which is
reduced to $0.11 if only %CD4/lymphocyte is required,
by using a CD4/CD45 antibody combination with
reduced volumes of blood and reagents (4).
The Blantyre count technology has recently been
transferred from a research laboratory to the EPICS XL-
MCL ﬂow cytometer (Beckman Coulter) at the College
of Medicine in Blantyre. In this study we assessed the
agreement of this method for affordable %CD4/lympho-
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pediatric venous blood samples. All ﬂow cytometric
operations were performed by Malawian laboratory tech-
nicians.
MATERIALS AND METHODS
Setting
Blantyre is the largest city in Malawi and is the princi-
pal city in the Southern Region of the country. The Col-
lege of Medicine, University of Malawi, is the only medi-
cal school in Malawi and is situated adjacent to Queen
Elizabeth Central Hospital (QECH), the largest hospital
in Malawi. The hospital has busy adult and pediatric anti-
retroviral clinics, as well as inpatient facilities.
Instrumentation
Flow cytometric CD4 counting was performed using
an EPICS XL-MCL ﬂow cytometer (Beckman Coulter) in
the Department of Biochemistry, College of Medicine.
This instrument came into clinical service in 2005. Inter-
nal quality control is performed daily on the ﬂow cytom-
eter using Immuno-Trol cells (Beckman Coulter).
Blood Samples
All blood samples used in the study were EDTA-antico-
agulated blood from HIV-seropositive children. Samples
were sent to the laboratory from QECH and health cen-
ters in Blantyre for CD4-positive lymphocyte determina-
tion. All samples used in the repeatability, stability, and
assay comparison studies were venous blood samples.
During the course of the study, we published a valida-
tion in adults of the use of ﬁnger-prick blood samples
for CD4-positive lymphocyte enumeration (11) and sub-
sequently began to use ﬁnger-prick blood samples clini-
cally for %CD4/lymphocyte determination in children
where attempts to obtain a venous blood sample had
been unsuccessful. Approximately, 10 samples were
taken by this method. These were not included among
the 113 samples in the Blantyre count/Panleucogate
agreement study.
Assay Operators
Both index test and reference standard ﬂow cytometric
assays were performed on each sample by one of the two
Malawian laboratory technicians, both holding Diplomas
in Laboratory Technology and one with a BTech in Bio-
medical Technology. Both technicians had experience of
performing the Panleucogate CD4-counting assay (PLG,
Beckman Coulter) (9), but no other ﬂow cytometric
assays. Both technicians had attended a 1-week training
course in the general operation of the EPICS XL-MCL ﬂow
cytometer arranged locally by Beckman Coulter. They
received a half-day of training in the Blantyre count
method from Dr. C. A. MacLennan in the College of Medi-
cine ﬂow cytometry laboratory in Blantyre.
Reference Standard (Panleucogate Assay)
The Panleucogate method was used as the reference
standard, because it is a robust established commercial
ﬂow-cytometric CD4 counting assay that determines
%CD4/lymphocyte values as well as absolute CD4
counts, and is recommended for use on Beckman
Coulter EPICS ﬂow cytometers, and was developed and
is extensively used in South Africa (9,10). Panleucogate
assays were performed according to the manufacturer’s
instructions (12). One hundred microliters of EDTA-anti-
coagulated venous blood was mixed with 10 ll of CD45-
FITC/CD4-PE antibody (FlowCare PLG CD4 Reagent,
Beckman Coulter) and incubated for 20 min at room
temperature in the dark. Red cells were then lysed using
the ImmunoPrep Reagent System and automated TQ-
Prep Workstation (both Beckman Coulter). Data acquisi-
tion and analysis were performed on the EPICS XL-MCL
ﬂow cytometer using the Panleucogate gating strategy
and System II Software Version 3.0 (Beckman Coulter).
With the Panleucogate gating strategy (9,10), 5,000
lymphocytes are acquired per sample with threshold for
acquisition set on the forward scatter (size) channel.
Total leucocytes (the panleucogate) and total lympho-
cytes are ﬁrst gated using a CD45-FITC (logarithmic
scale) against side scatter (logarithmic scale) dot plot
(Fig. 1a). CD4-positive lymphocytes are then determined
by gating the CD4-bright population using a CD4-PE (log-
arithmic scale) against side-scatter (logarithmic scale) dot
plot of the total lymphocyte population (Fig. 1b). %CD4/
lymphocyte is determined from the CD4-positive lym-
phocyte and total lymphocyte values.
CD4 counting at the College of Medicine using the
Panleucogate assay has recently been enrolled for exter-
nal quality assurance monitoring with UK NEQAS (13).
Testing the six most recent samples distributed by UK
NEQAS gave a score of 11 out of a maximum possible
12 for the %CD4/lymphocyte parameter: %CD4/lympho-
cyte values for 5/6 samples were within 1 standard devi-
ation and 1/6 samples was within 2 standard deviations
of the UK NEQAS value.
Index Test (Blantyre Count Assay)
The Blantyre count method for %CD4/lymphocyte
determination was essentially the Blantyre count (per-
centage) variant described previously (4) with modiﬁca-
tions for using pediatric blood samples and the EPICS
XL-MCL ﬂow cytometer. These modiﬁcations involved
increasing the volume of the two antibodies used from
0.5 to 1.0 ll each and establishing the Blantyre count
gating strategy on the System II Software supplied with
the EPICS XL-MCL ﬂow cytometer. We previously vali-
dated the use of 0.5 ll of each antibody as twice the
minimum amount required to distinguish CD4-positive
and total lymphocytes as discrete populations in adult
blood. The amount of antibody used in the present study
was increased because the blood lymphocyte counts in
children are higher than in adults. The actual antibodies
and red cell lysing ﬂuid used were the same as those in
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Cytometry Part B: Clinical CytometryFIG. 1. Panleucogate and Blantyre count gating strategies for %CD4/lymphocyte determination using System II Software. (a and b) Panleucogate
strategy on venous blood sample with (a) CD45(log)/sidescatter(log) dot plot showing total leucocytes gate (the Panleucogate) (A) and total lympho-
cytes (B), (b) CD4(log)/sidescatter(log) dot plot of total lymphocytes (A) showing CD4-positive lymphocytes (D). (c and d) Blantyre count strategy on
venous blood sample with (c) CD45(log)/sidescatter(linear) dot plot showing total lymphocytes (A), (d) CD4(log)/sidescatter(linear) dot plot of total
lymphocytes (A) showing CD4-positive lymphocytes (B). Same venous blood sample as used in (a) and (b). (e and f) Blantyre count strategy on ﬁn-
ger-prick blood sample with (e) CD45(log)/sidescatter(linear) dot plot showing total lymphocyte gate (A), (f) CD4(log)/sidescatter(linear) dot plot of
total lymphocytes showing CD4-positive lymphocytes (B). %CD4/lymphocyte values are calculated directly from the number of cells in the CD4-posi-
tive lymphocyte region and number of cells in the total lymphocyte region. SS, side-scattered light.
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method is a noncommercial method and although similar
to the Panleucogate method, differs from it in the follow-
ing respects: smaller volumes of blood and antibodies
are used, red cell lysis is performed without the use of
an automated workstation, threshold for acquisition is
set on the FL1 (FITC) channel rather than forward light
scatter, and a linear rather than logarithmic side light
scatter scale is used in the gating strategy.
One microliter of phycoerythrin-conjugated anti-
human CD4 antibody (CD4-PE) and 1 ll of ﬂuorescein
isothiocyanate-conjugated anti-human CD45 antibody
(CD45-FITC) (both Becton Dickinson) were mixed with
20 ll of EDTA-anticoagulated venous blood and incu-
bated in the dark at room temperature for 15 min. One
hundred eighty microliters of 13 FACS lysing solution
(Becton Dickinson) was then added to lyse red cells and
the solution was further incubated for 10 min at room
temperature in the dark prior to acquisition and analysis
of data on the ﬂow cytometer using the Blantyre count
gating strategy and System II Software. Pipetman P20
and P200 pipettes (Gilson, France) were used for all
pipetting steps. The Blantyre count gating strategy has
been described previously (4). Five thousand lymphocyte
events are acquired per sample with threshold for acqui-
sition set on the FL1 (FITC) channel. Total lymphocytes
for each acquisition are determined by gating the side
scatter-low CD45-bright population using a CD45-FITC
(logarithmic scale) against side scatter (linear scale) dot
plot (Fig. 1c). CD4-positive lymphocytes are determined
by gating the CD4-bright population using a CD4-PE (log-
arithmic scale) against side-scatter (linear scale) dot plot
of the total lymphocyte population (Fig. 1d). %CD4/lym-
phocyte values were determined from these two values.
Repeatability, Stability, and Interoperator Variability
Repeatability was assessed by performing ﬁve repeats
of the Blantyre count assay on six fresh blood samples.
Stability was assessed by performing ﬁve repeats of the
assay daily on two blood samples for 5 days. The blood
samples were kept at room temperature throughout the
5-day period.
To estimate interoperator variability in the sample
preparation stages (pipetting, antibody labeling, and red
cell lysis) and conﬁrm ease of use of the Blantyre count
method, two groups of students (n 5 9 and 8) in the
second year of their Diploma in Laboratory Technology
course at the University of Malawi performed the Blan-
tyre count assay following a standard operating proce-
dure. The students had no prior experience of the assay.
Assay Comparison Study
One hundred thirteen consecutive pediatric venous
blood samples received in the laboratory for CD4 deter-
mination between March 14, 2007 and May 4, 2007
were assayed for %CD4/lymphocyte using both Panleuco-
gate and Blantyre count assays within an hour of each
other. All samples were from HIV-seropositive children.
HIV-seropositive children under 18 months presenting
with a clinical illness, potentially HIV-related, were
included, but conﬁrmatory PCR diagnosis was not avail-
able. Samples were rejected if clotted or incorrectly la-
beled. There were no other inclusion or exclusion crite-
ria. Samples were assayed within 24 h of venesection.
Data collection was planned before the assays were per-
formed. All blood samples from all participants under-
went the index and reference standard tests. No adverse
events occurred from performing these tests. Analysis
was performed blinded to the results of the paired assay.
No data were missing and all data were used. No cut-offs
were applied to the results.
Statistical Analysis
Agreement between methods was examined using
Stata 9 by estimating bias and limits of agreement (bias
6 1.96 SD) with 95% conﬁdence intervals as described
by Bland and Altman (14). Repeatability was assessed
using coefﬁcients of variation obtained from ﬁve repeats
of assays.
RESULTS
Characteristics of Patients
All blood samples were from HIV-seropositive children
(51% male) attending HIV staging and treatment clinics
at Queen Elizabeth Central Hospital and health centers
in Blantyre. Twenty-six children were less than 18
months old and median age of all children was 38
months. Most children were ambulatory and attending
outpatient services, with 14% of samples taken from
inpatients. Twenty-two percent of children were recover-
ing from severe acute malnutrition. Clinical staging was
by WHO criteria (2), and was available for 63 children.
Of these, 33% were stage I or II, and 67% stage III or IV
or presumptive diagnosis (if under 18 months). Immuno-
logical staging of all children using WHO age-speciﬁc
%CD4/lymphocyte cut-offs (2) found that 65% were
severely immunosuppressed. Only two children were
currently on antiretroviral therapy. Children meeting
clinical or immunological staging criteria for starting anti-
retroviral therapy were referred for this.
%CD4/Lymphocyte Values in Agreement Studies
The median %CD4/lymphocyte value by the Panleuco-
gate method was 13.7% (mean 9.51%, range 0.73–
51.2%). The median %CD4/lymphocyte value by the
Blantyre count method was 13.8% (mean 9.75%, range
1.42–51.5%). Agreement between %CD4/lymphocyte val-
ues obtained using the two methods was excellent with
a mean difference (bias) of 20.13% (CI 20.37 to 0.11)
and limits of agreement 22.69 to 2.43% (CI 23.11 to
22.27 and 2.01 to 2.85) (Fig. 2, Table 1). When data
were analyzed according to assay operator, similar bias
and limits of agreement were obtained for both labora-
tory technicians with biases of 20.17 and 20.07% and
limits of agreement within 23.00 and 3.00 (Table 1).
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Mean %CD4/lymphocyte values for each of the six
blood samples tested were 15.8 to 30.0%. Mean coefﬁ-
cient of variation for the Blantyre count assay was 2.0%
(range 0.9–3.5%). There was no association between
%CD4/lymphocyte value and coefﬁcient of variation.
These coefﬁcients of variation are similar to the pub-
lished values from the manufacturer for the Panleucogate
method (1.67% using control cells with a %CD4/lympho-
cyte of 48.1%; 3.18% using control cells with a %CD4/
lymphocyte of 22.0%) (12).
Stability Study
For the duration of the stability study, total lympho-
cytes and CD4-positive lymphocyte populations could be
clearly distinguished. There was a gradual increase in
%CD4/lymphocyte of the two samples tested such that
the day 5 values were 2.6 and 2.3% higher than the day
1 values. Although coefﬁcients of variation were lowest
for the day 1 values, there was no clear trend and these
ranged from 1.6 to 6.1%.
Interoperator Variability Study
Coefﬁcients of variation for %CD4/lymphocyte values
obtained by each group of students using one blood
sample in each group were 2.5 and 0.8%. The mean val-
ues obtained by each group were within 0.3% of the
value obtained by the class instructor.
Finger-Prick Blood Samples
Following on from our recent validation of ﬁnger-prick
blood samples for CD4-lymphocyte determination in
adults (11), we encountered no difﬁculties in labeling
and gating CD4-lymphocyte and total lymphocyte popu-
lations for the determination of %CD4/lymphocyte val-
ues in ﬁnger-prick samples taken from children using
the Blantyre count method with the EPICS XL-MCL ﬂow
cytometer (Figs. 1e and 1f).
DISCUSSION
The Blantyre count method was originally developed
as a simpliﬁed affordable method of CD4 counting using
a Becton Dickinson ﬂow cytometer and reagents, on
blood samples from HIV-infected Malawian adults (4). In
the present study, we demonstrate the successful trans-
fer of this technology in its simplest form with only min-
imal modiﬁcations (increased antibody quantities and
Blantyre count gating strategy on System II Software) for
%CD4/lymphocyte determination in venous blood from
HIV-infected Malawian children using a Beckman Coulter
ﬂow cytometer.
The rationale for the present study was to provide
accurate low cost %CD4/lymphocyte values for the
Department of Pediatrics at Queen Elizabeth Central
Hospital where previously only the reversed dual-plat-
form FACSCount approach had been available. The mini-
mal bias and narrow limits of agreement obtained when
comparing the Blantyre count and Panleucogate methods
in the present study indicate the accuracy of Blantyre
count for %CD4/lymphocyte determination in pediatric
blood samples on a Beckman Coulter ﬂow cytometer.
Of equal signiﬁcance is the low cost of reagents asso-
ciated with this approach. Using locally available prices,
the reagent costs per Blantyre count %CD4/lymphocyte
Table 1
Estimated Bias and Limits of Agreement, with 95% Conﬁdence Intervals for Percentage CD4 Cell Counts (%CD4/Lymphocyte)
Determined by Blantyre Count and Panleucogate Assays on 113 Venous Blood Samples from HIV-Seropositive Malawian Children.
Overall Values and Values for Each Laboratory Technician Are Given
Samples Bias
95% Conﬁdence
interval
Limits of agreement
Lower
limit
95% Conﬁdence
interval Upper limit
95% Conﬁdence
interval
Overall 113 20.13 (20.37 to 0.11) 22.69 (23.11 to 22.27) 2.43 (2.01 to 2.85)
Technician 1 67 20.17 (20.46 to 0.12) 22.48 (22.98 to 21.98) 2.14 (1.64 to 2.64)
Technician 2 46 20.07 (20.51 to 0.37) 22.98 (23.74 to 22.21) 2.83 (2.07 to 3.59)
FIG. 2. Comparison of CD4 counts determined as a percentage of
total lymphocyte count (%CD4/lymphocyte) using the Blantyre count
and Panleucogate methods with 113 venous blood samples from HIV-
seropositive Malawian children. Mean %CD4/lymphocyte values are the
average of the %CD4/lymphocyte values generated by the Blantyre
count and Panleucogate methods for each sample. Black lines depict
bias and upper and lower limits of agreement. Gray lines denote 95%
conﬁdence intervals for these values.
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on the best locally available price of the Panleucogate
and FACSCount assays (both $6 per test). The Blantyre
count reagent cost is greater than that given previously
(4), because we used twice the amount of antibodies
compared with the original Blantyre count study. How-
ever, while performing this study, we have reduced the
reagent cost further by using generic monoclonal anti-
bodies in the Blantyre count assay as has been described
previously (15).
Whereas all ﬂow cytometric operations in the original
Blantyre count study were performed by scientists hold-
ing PhDs in immunology and with considerable experi-
ence of ﬂow cytometry, all experimental procedures in
the present study were performed by laboratory techni-
cians with minimal ﬂow cytometry training. This indi-
cates that the Blantyre count methodology is appropriate
for use by local staff in Malawi, given appropriate techni-
cal training and support.
Where highly skilled laboratory staff and accurately
calibrated pipettes may not be available (16), the Blan-
tyre count technique has the advantage that precise
pipetting accuracy is not critical for %CD4/lymphocyte
determination, since the CD41 T-lymphocyte number is
measured as a ratio of the total lymphocyte number in
the same tube of blood. Use of this cell ratio is probably
the reason for the low coefﬁcients of variation both in
the repeatability study and in the interoperator variabili-
ty study with student laboratory technicians. It may also
account for the relative stability of %CD4/lymphocyte
values in aged blood samples, since loss of lymphocytes
with time is likely to affect both CD4-positive and CD4-
negative lymphocytes to similar degrees.
This lack of reliance on accurate pipetting is in con-
trast to absolute CD4-positive lymphocyte enumeration
on the majority of single platform ﬂow cytometer opera-
tions as well as many nonﬂow cytometric methods,
where use of precise blood and counting bead volumes
is essential. In addition, any strategy that relies on ﬁrst
generating an absolute CD4 count and then deriving the
percentage value from a total lymphocyte count is likely
to suffer the same pitfall as using this ‘‘reversed-dual plat-
form’’ approach with the FACSCount instrument. Thus
even with the possible advent of CD4 ‘‘rapid tests’’ (17)
for absolute CD4 counts in the future, the ﬂow cytome-
ter should retain its position as the methodology of
choice for CD4 percentage determination.
Compared with the Blantyre count method previously
published, we doubled the quantities of CD4-PE and
CD45-FITC antibody used per test, in view of the higher
number of lymphocytes in pediatric compared with
adult blood samples. This was to ensure adequate label-
ing to distinguish total lymphocytes and the CD4-positive
lymphocyte subset. Otherwise our sample preparation
was identical to that described previously (4). We contin-
ued to use FACS lysing solution (Becton Dickinson) for
red cell lysis and ﬁxation rather than the ImmunoPrep
Reagent system and TQ-Prep Workstation (Beckman
Coulter) as recommended by the manufacturer of the
Panleucogate method. This suggests that for %CD4/lym-
phocyte determination on the EPICS instrument, use of
the Coulter TQ-Prep Workstation is not necessary.
As with the established Blantyre count method and in
contrast with the Panleucogate method, threshold for ac-
quisition was set on the FL1 (CD45-FITC) channel rather
than forward light scatter, the side light scatter parame-
ter was set to a linear rather than a log scale to aid dis-
crimination of lymphocytes and monocytes, and a total
lymphocyte rather than total leucocyte primary gate was
utilized.
We have recently validated the use of ﬁnger-prick blood
samples for ﬂow cytometric CD4 counting (11), indicating
that even in rural settings in Malawi where a trained phle-
botomist is not available, %CD4/lymphocyte could be
obtained on patients by transporting ﬁnger-prick blood
samples to the regional centers. Finger-prick blood sam-
ples are successfully being used in our clinics for children
where venous sampling has not been possible.
Robust external quality assurance of each CD4 count-
ing method used in each laboratory is essential to avoid
inaccuracies in CD4 testing. Since its development early
in 2006, the Blantyre count method has been registered
for external quality assurance with UK NEQAS at the Ma-
lawi-Liverpool-Wellcome Trust Clinical Research Pro-
gramme. The method currently has a maximum score of
12 for %CD4/lymphocyte values indicating that within
the last 6 months, %CD4/lymphocyte values on all UK
NEQAS samples tested have been within 1 standard devi-
ation of the target value. We are in the process of regis-
tering the Blantyre count method with UK NEQAS for
%CD4/lymphocyte determination on the EPICS ﬂow cy-
tometer at the College of Medicine.
With the almost negligible reagent costs incurred by
using generic antibodies with the Blantyre count method
described in this article, attention must now focus on
nonreagent costs. These include capital outlay for the
ﬂow cytometer, maintenance contracts, and staff salaries
and as such are relatively ﬁxed so that the overall cost
per assay becomes inversely proportional to the assay
throughput. Flow cytometers have the advantage over
nonﬂow cytometric methodologies and the FACSCount
instrument in being able to handle over 250 samples a
day with ease (18). Therefore, a cost-effective system
would aim to operate at this level.
Currently there is no coordinated national program or
strategy for CD4 counting in Malawi for either percent-
age or absolute counts. The advantages and disadvan-
tages of centralized versus decentralized models would
need to be considered for such a program taking into
account the costs of instruments and their maintenance
together with practicalities of sample and/or patient
transport and results dissemination.
There are three regional capitals in Malawi: Blantyre
(Southern Region), Lilongwe (Central Region), and
Mzuzu (Northern region). Each of these centers already
has a Beckman Coulter EPICS ﬂow cytometer in place,
and so establishment of Blantyre count technology in
the remaining two cities is potentially straightforward.
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ble over a period of days, and distances in Malawi are
relatively small, a national %CD4/lymphocyte service
based on these three centers may be feasible.
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